Article Information
History
- May 26, 2021.
Article Versions
- You are currently viewing Version 1 of this article (May 26, 2021 - 05:19).
- Version 2 (May 26, 2021 - 09:19).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Harald S. Vöhringer1,2,
- Theo Sanderson3,4,
- Matthew Sinnott3,
- Nicola De Maio1,
- Thuy Nguyen3,
- Richard Goater3,
- Frank Schwach3,5,
- Ian Harrison5,
- Joel Hellewell6,
- Cristina Ariani3,
- Sonia Gonçalves3,
- David Jackson3,
- Ian Johnston3,
- Alexander W. Jung1,
- Callum Saint3,
- John Sillitoe3,
- Maria Suciu3,
- Nick Goldman1,
- The Wellcome Sanger Institute Covid-19 Surveillance Team7,
- The COVID-19 Genomics UK (COG-UK) Consortium8,
- Ewan Birney1,
- Sebastian Funk6,
- Erik Volz9,
- Dominic Kwiatkowski3,
- Meera Chand5,
- Inigo Martincorena3,
- Jeffrey C. Barrett3,* and
- Moritz Gerstung1,10,*
- 1European Molecular Biology Laboratory, European Bioinformatics Institute EMBL-EBI, Hinxton, UK
- 2Joint Biosecurity Center JBC
- 3Wellcome Sanger Institute, Hinxton, UK
- 4The Francis Crick Institute, London, UK
- 5Public Health England PHE
- 6London School of Hygiene & Tropical Medicine, London, UK
- 9Imperial College, London, UK
- 10German Cancer Research Centre dkfz, Heidelberg, Germany
- ↵*Correspondence to Jeffrey C. Barrett jb26{at}sanger.ac.uk or Moritz Gerstung moritz.gerstung{at}ebi.ac.uk, Moritz Gerstung, European Bioinformatic Institute EMBL-EBI, Wellcome Genome Campus, Hinxton, CB10 2LP, United Kingdom, Jeffrey C. Barrett, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, CB10 1SA, United Kingdom